Genuine concern for end-users and a sound business model have made Karma Medical Products the largest supplier of quality wheelchairs and mobility products in Asia. "While our competitors think only of selling more wheelchairs, we focus on the people who will be using them," says CEO Kenny Chen. Chen has imposed a culture of continuous development across all aspects of Karma Medical's business including research and development and marketing. The research and development department is the industry's biggest in Asia and has more than 100 worldwide patents including industry-standard technologies. The marketing team has devised an intelligent approach creating the Karma brand for Taiwan, Japan, Europe and other developed countries and the Soma brand for developing markets. This business model has helped Karma Medical to grow over the past 25 years. From a small company with only three people, it is now one of Asia's largest wheelchair providers employing more than 500 people in Taiwan, Thailand, the mainland, India and Britain. Recognising significant growth on the mainland, Karma Medical will set up a new factory in Zhejiang which will start production of middle-range wheelchairs by early next year. The focus on the mainland is part of the company's long-term marketing strategy which reinforces sales to developing countries to 60 per cent from 20 per cent of total turnover. Karma Medical has produced several high-end products for this year. These include upgraded models for standing-up wheelchairs and power wheelchairs. The company will also launch the Ultralight model which weighs half the regular product at only eight kilograms. "We don't design our products by ourselves. After conducting market research and mechanical design, we invite therapists to review the products for possible modifications," Chen says. "A better wheelchair ensures a better fit. We make sure every wheelchair we deliver to our customers truly fits their needs."